"The prognosis for patients with relapsed or refractory follicular lymphoma has significantly improved over the last couple of years," he said. "We have several options, and our goal now is to ...

Follicular lymphoma is much less common in children ... absence of histological transformation was associated with a good prognosis even for patients with early relapse. Progression Within 24 ...

Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

Your doctor may use radiation therapy to either attempt to cure the cancer or to help treat symptoms of lymphoma. Curative radiation therapy is given with the aim of achieving remission (no ...

Symptoms of non-Hodgkin's lymphoma may include painless swelling of one or more lymph nodes, night sweats, itching, and more. Doctors divide non-Hodgkin's lymphoma into types based on the kind of ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.